Clinical Development Reports. 26 3.9 Technology Outside the Field of Use.....................................26 4.0 Supply of Interferon Gamma-1B....................................................29 4.1 Bulk Product and Finished Product.......................................29 4.2 Supply of Non-human Interferon Gamma....................................29
Appears in 2 contracts
Sources: Exclusive Sublicense Agreement (Intermune Pharmaceuticals Inc), Exclusive Sublicense Agreement (Intermune Pharmaceuticals Inc)